* Speakers confirmed to-date. Please check back as new speakers are being added

Co-Chairs

Jason R. Parish

Shareholder
Buchanan Ingersoll & Rooney PC

Richard S. Hartunian

Partner
Manatt, Phelps & Phillips, LLP

Government

Dominic Chiapperino, Ph.D.

Director, Controlled Substance Staff
Center for Drug Evaluation and Research
Food and Drug Administration

Gustav Eyler

Director, Consumer Protection Branch
U.S. Department of Justice

Ross Goldstein

Senior Litigation Counsel
U.S. Department of Justice

Elliot M. Schachner

Assistant U.S Attorney, U.S. Attorney’s Office
Eastern District of New York

Claire M. Brennan

Section Chief, Liaison Section, Diversion Control Division
U.S. Drug Enforcement Administration

Scott A. Brinks

Section Chief Regulatory Drafting & Policy Support Section Diversion Control Division
U.S. Drug Enforcement Administration

In-House and Outside Counsel

Susan E. Briones

Partner
Lewis Brisbois

Ronald W. Chapman II

Shareholder
Chapman Law Group

Shannon F. Cox

Counsel
King & Spalding LLP

Hunter DeKoninck

Attorney
Quarles & Brady LLP

Joseph Fortunak

Professor, Chemistry and Pharmaceutical Sciences
Howard University

Ronald J. Friedman

Shareholder
Karr Tuttle Campbell

John A. Gilbert, Jr.

Director
Hyman, Phelps & McNamara PC

Todd H. Halpern

Assistant General Counsel, Legal Operations-MSC, Consumer Healthcare Quality, CMO and EHS
GSK

Jennifer Razor

Managing Partner
Cirrina Legal

Kinsey S. Reagan

Partner
Kleinfeld Kaplan & Becker LLP

David Schiller

Former Assistant Special Agent in Charge, U.S. DEA
Presider & CEO and CoFounder
NarcX

Will Woodlee

Partner
Kleinfeld Kaplan & Becker LLP